We are live on ! Find out more
BDSX icon

Biodesix

29 hedge funds and large institutions have $20.7M invested in Biodesix in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

0% more ownership

Funds ownership: 1.07%1.07% (+0%)

3% less funds holding

Funds holding: 3029 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

33% less capital invested

Capital invested by funds: $31M → $20.7M (-$10.3M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
29
Holders Change
-1
Holders Change %
-3.33%
% of All Funds
0.46%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
4
Increased
10
Reduced
5
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Barclays
26
Barclays
United Kingdom
$304 +$360 +12 New
UBS Group
27
UBS Group
Switzerland
$185
GI
28
Gradient Investments
Minnesota
$123 +$150 +5 New
ECM
29
Endurant Capital Management
California
-$211K -5,663 Closed
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
-$68.5K -1,841 Closed
HF
31
HRT Financial
New York
-$61K -1,645 Closed
Bank of America
32
Bank of America
North Carolina
-$564 -15 Closed
Simplex Trading
33
Simplex Trading
Illinois
+$150 +5 New

BDSX Hedge Fund Activity: Q2 2023 in Review

29 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q2 2023, worth a combined $20.7M — down 33% from $31M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of BDSX and 4 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 10 added.

The largest buyer was State Street, adding an estimated $377K. The largest seller was AIGH Capital Management, cutting an estimated $724K.

  • 29 institutional investors held Biodesix (BDSX) as of Q2 2023, down from 30 in Q1 2023.
  • Funds reported $20.7M of Biodesix stock for Q2 2023, down 33% quarter-over-quarter.
  • 4 funds opened new Biodesix positions in Q2 2023 and 5 closed out, a net change of -1 holder.
  • The largest Biodesix buyer in Q2 2023 was State Street, an estimated $377K added.
  • The largest Biodesix seller in Q2 2023 was AIGH Capital Management, an estimated $724K sold.

Based on aggregated 13F filings for Q2 2023.